During their laboratory experiments, the researchers discovered that the cholesterol-lowering drug "fenofibrate", which is marketed as TriCor, effectively reduced the damage to lung cells and stopped the spread of the Corona virus.
The agency stated that the study targeted only 15 patients; Which means it still needs to scale up trials to confirm the results.
Alan Richardson, a pharmacologist at Keele University in Staffordshire, England, said: "The results show that fenofibrate can reduce a patient's chance of hospitalization, and can also reduce the time spent in hospital, reduce his need for oxygen, and may also reduce death danger.
He added, "I am cautiously optimistic, given that the study targeted a very small number of patients; So I warned.
